Using Synthetic Biology to Craft One-Time, Programmable mRNA Therapeutics

26:30
 
Share
 

Manage episode 293479914 series 49047
By The Bio Report. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
The marriage of synthetic biology to mRNA is creating the potential for a range of programmable therapeutics that can provide new ways of treating deadly and chronic diseases. Strand Therapeutics is creating a platform for developing these long-acting mRNA drugs that it says can be precise, multi-functional, and deliver potentially curative treatments with a single dose. We spoke to Jake Becraft, co-founder and CEO of Strand, about the company’s programmable mRNA therapeutic platform, how it works, and the indications it is pursuing.

374 episodes